Aventura, FLNCT05638295Now EnrollingIRB Ready

KRAS Mutant Cancer Clinical Trial in Aventura, FL

Access cutting-edge kras mutant cancer treatment through this clinical trial at a research site in Aventura. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Aventura location

Preparing your pre-screening questions...

Expert Care in Aventura

Access kras mutant cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kras mutant cancer treatment provided free

Apply for This Aventura Location

Check if you qualify for this kras mutant cancer clinical trial in Aventura, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aventura

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aventura site if eligible
  4. 4Begin participation

About This KRAS Mutant Cancer Study in Aventura

This phase II ComboMATCH treatment trial tests how well AMG 510 (sotorasib) with or without panitumumab works in treating patients with KRAS G12C mutant solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells. Pan

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

Patient must have enrolled onto EAY191 and must have been given a treatment assignment to ComboMATCH to EAY191-E5 based on the presence of an actionable mutation as defined in EAY191
Patient must be enrolled on the ComboMATCH Registration Protocol (EAY191) at the time of registration/randomization to the EAY191-E5 study
Patient must be \>= 18 years of age
Patient must have a KRAS G12C alteration as determined by the ComboMATCH screening assessment
Patient must have disease that can be safely biopsied and agree to a pre-treatment biopsy or have tissue available from within 12 months prior to the date of registration on the ComboMATCH Registration Trial (EAY191-E5)
NOTE: The current actionable marker of interest (aMOI)/actionable alteration list for this treatment trial can be found on the Cancer Trials Support Unit (CTSU) website: www.ctsu.org (final URL pending)
NOTE: Novel/Dynamic aMOI can be submitted for review per the process described in the

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aventura?

Yes, this clinical trial (NCT05638295) has an active research site in Aventura, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

KRAS Mutant Cancer Treatment Options in Aventura, FL

If you're searching for kras mutant cancer treatment options in Aventura, FL, this clinical trial (NCT05638295) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aventura research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kras mutant cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kras mutant cancer clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Aventura, FL

See all rheumatoid arthritis clinical trials recruiting in Aventura — not just this study.

Browse Rheumatoid Arthritis Trials in Aventura

Ready to Join in Aventura?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aventura, FL